Successful Discontinuation of Eculizumab in a Pediatric Patient With Atypical Hemolytic Uremic Syndrome and Underlying Systematic Lupus Erythematosus.

Saved in:
Bibliographic Details
Title: Successful Discontinuation of Eculizumab in a Pediatric Patient With Atypical Hemolytic Uremic Syndrome and Underlying Systematic Lupus Erythematosus.
Authors: Alhamoud I; Pediatric Nephrology, University of Iowa, Iowa City, USA., Freiberg SA; Pediatric Nephrology, University of Iowa, Iowa City, USA.
Source: Cureus [Cureus] 2022 May 18; Vol. 14 (5), pp. e25117. Date of Electronic Publication: 2022 May 18 (Print Publication: 2022).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2168-8184
DOI:10.7759/cureus.25117